OR WAIT null SECS
April 24, 2013
FDA will use a new anticounterfeiting tool to detect fake medicines.
April 23, 2013
EMA has upgraded its EudraGMP database to include information on GDP in addition to GMP. The new EudraGMDP database is a key deliverable of the Falsified Medicines Directive (FMD) that came into effect in January 2013. The aim is to increase supply chain security in the EU by making supervision of manufacturing and distribution of medicines more robust to ensure supplier compliance.
April 12, 2013
Mary Storch, a member of the planning PDA supply chain committee, is associate director, external QA oversight, for Ben Venue Laboratories. She discusses parenteral drug-supply chain challenges, in terms of the complexity of the raw materials supplied as well as additional consideration in end-product distribution, such as cold-chain requirements.
April 10, 2013
As the strategic value of emerging markets increase, pharmaceutical companies increase their R&D and manufacturing investments.
March 20, 2013
Bristol-Myers Squibb embarks on a multi-year journey to overcome the challenges of serialization and reap the benefits.
March 12, 2013
INTERPOL and 29 of the world’s largest pharmaceutical companies have joined forces in an initiative to battle counterfeit drugs.
March 02, 2013
February 20, 2013
Equipment purchased today for the packaging line should be serialization-ready in preparation for upcoming requirements.
February 02, 2013
Medication safety and efficacy depend on maintaining products at the proper temperature.
Protecting patients from counterfeit medicines is a pressing issue facing governments and the pharmaceutical industry.